Sideris Pharmaceuticals

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Sideris Pharmaceuticals - overview

Location

Boston, MA, US

Primary Industry

Biotechnology

About

Sideris Pharmaceuticals is based in the United States and operates as an independent biopharmaceutical company focused on the development of treatments for diseases of iron overload, including conditions involving maintenance transfusion therapy.


Current Investors

Hatteras Venture Partners, OUP (Osage University Partners), MPM BioImpact

Primary Industry

Biotechnology

Sub Industries

Biopharmaceuticals

Website

www.siderispharma.com

Verticals

HealthTech

Total Amount Raised

Subscriber access only

Sideris Pharmaceuticals - employee data

Blurred Background

Want to see Employee Count?

Request a demo for full access to this profile.

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.